Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Nov 27, 2026; 18(11): 124030
Published online Nov 27, 2026. doi: 10.4240/wjgs.124030
Published online Nov 27, 2026. doi: 10.4240/wjgs.124030
Table 6 Multivariate analysis of acute kidney injury after liver cancer ablation
| Indicators | B | SE | Wald | P value | OR | 95%CI |
| Age (years) | 0.812 | 0.586 | 1.921 | 0.166 | 2.252 | 0.714-7.100 |
| Comorbid diabetes | 1.229 | 0.639 | 3.695 | 0.055 | 3.418 | 0.976-11.969 |
| TNM staging | 0.543 | 0.675 | 0.648 | 0.421 | 1.722 | 0.459-6.462 |
| Tumor length (cm) | 0.310 | 0.162 | 3.669 | 0.055 | 1.363 | 0.993-1.872 |
| Hemoglobin (g/L) | -0.097 | 0.023 | 17.277 | < 0.001 | 0.908 | 0.867-0.950 |
| Uric acid (μmol/L) | 0.001 | 0.003 | 0.064 | 0.801 | 1.001 | 0.994-1.008 |
| Creatinine (μmol/L) | 0.039 | 0.018 | 4.649 | 0.031 | 1.040 | 1.004–1.078 |
- Citation: Luo DW, Du HL, Duan WX. Acute kidney injury after liver cancer ablation: Risk factors and perioperative management. World J Gastrointest Surg 2026; 18(11): 124030
- URL: https://www.wjgnet.com/1948-9366/full/v18/i11/124030.htm
- DOI: https://dx.doi.org/10.4240/wjgs.124030